282 related articles for article (PubMed ID: 32416186)
1. Thrombomodulin alfa prevents oxaliplatin-induced neuropathic symptoms through activation of thrombin-activatable fibrinolysis inhibitor and protein C without affecting anti-tumor activity.
Minami T; Takeda M; Sata M; Kato H; Yano K; Sakai T; Tsujita R; Kawasaki K; Ito A
Eur J Pharmacol; 2020 Aug; 880():173196. PubMed ID: 32416186
[TBL] [Abstract][Full Text] [Related]
2. Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents.
Ushio S; Egashira N; Sada H; Kawashiri T; Shirahama M; Masuguchi K; Oishi R
Eur J Cancer; 2012 Jun; 48(9):1407-13. PubMed ID: 21907570
[TBL] [Abstract][Full Text] [Related]
3. Protective Effect of a Mitochondria-Targeted Peptide against the Development of Chemotherapy-Induced Peripheral Neuropathy in Mice.
Toyama S; Shimoyama N; Szeto HH; Schiller PW; Shimoyama M
ACS Chem Neurosci; 2018 Jul; 9(7):1566-1571. PubMed ID: 29660270
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of alogliptin on oxaliplatin-induced peripheral neuropathy in vivo and in vitro.
Shigematsu N; Kawashiri T; Kobayashi D; Shimizu S; Mine K; Hiromoto S; Uchida M; Egashira N; Shimazoe T
Sci Rep; 2020 Apr; 10(1):6734. PubMed ID: 32317735
[TBL] [Abstract][Full Text] [Related]
5. Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy.
Joseph EK; Chen X; Bogen O; Levine JD
J Pain; 2008 May; 9(5):463-72. PubMed ID: 18359667
[TBL] [Abstract][Full Text] [Related]
6. Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats.
Fujita S; Ushio S; Ozawa N; Masuguchi K; Kawashiri T; Oishi R; Egashira N
PLoS One; 2015; 10(11):e0141921. PubMed ID: 26536615
[TBL] [Abstract][Full Text] [Related]
7. Dimethyl Fumarate Attenuates Oxaliplatin-Induced Peripheral Neuropathy without Affecting the Anti-tumor Activity of Oxaliplatin in Rodents.
Miyagi A; Kawashiri T; Shimizu S; Shigematsu N; Kobayashi D; Shimazoe T
Biol Pharm Bull; 2019; 42(4):638-644. PubMed ID: 30930422
[TBL] [Abstract][Full Text] [Related]
8. Role of non-macrophage cell-derived HMGB1 in oxaliplatin-induced peripheral neuropathy and its prevention by the thrombin/thrombomodulin system in rodents: negative impact of anticoagulants.
Tsubota M; Fukuda R; Hayashi Y; Miyazaki T; Ueda S; Yamashita R; Koike N; Sekiguchi F; Wake H; Wakatsuki S; Ujiie Y; Araki T; Nishibori M; Kawabata A
J Neuroinflammation; 2019 Oct; 16(1):199. PubMed ID: 31666085
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of single doses of elcatonin and pregabalin on oxaliplatin-induced cold and mechanical allodynia in rats.
Aoki M; Kurauchi Y; Mori A; Nakahara T; Sakamoto K; Ishii K
Biol Pharm Bull; 2014; 37(2):322-6. PubMed ID: 24492729
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine Stress Axis-Dependence of Duloxetine Analgesia (Anti-Hyperalgesia) in Chemotherapy-Induced Peripheral Neuropathy.
Staurengo-Ferrari L; Bonet IJM; Araldi D; Green PG; Levine JD
J Neurosci; 2022 Jan; 42(3):405-415. PubMed ID: 34880120
[TBL] [Abstract][Full Text] [Related]
11. Rosmarinic Acid Mitigates Mitochondrial Dysfunction and Spinal Glial Activation in Oxaliplatin-induced Peripheral Neuropathy.
Areti A; Komirishetty P; Kalvala AK; Nellaiappan K; Kumar A
Mol Neurobiol; 2018 Sep; 55(9):7463-7475. PubMed ID: 29427084
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Bromhexine and its Active Metabolite - Ambroxol as Potential Analgesics Reducing Oxaliplatin-induced Neuropathic Pain - Pharmacodynamic and Molecular Docking Studies.
Furgała-Wojas A; Kowalska M; Nowaczyk A; Fijałkowski Ł; Sałat K
Curr Drug Metab; 2020; 21(7):548-561. PubMed ID: 32651960
[TBL] [Abstract][Full Text] [Related]
13. Analgesic Effect of Melittin on Oxaliplatin-Induced Peripheral Neuropathy in Rats.
Choi S; Chae HK; Heo H; Hahm DH; Kim W; Kim SK
Toxins (Basel); 2019 Jul; 11(7):. PubMed ID: 31288453
[TBL] [Abstract][Full Text] [Related]
14. Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathy.
Resta F; Micheli L; Laurino A; Spinelli V; Mello T; Sartiani L; Di Cesare Mannelli L; Cerbai E; Ghelardini C; Romanelli MN; Mannaioni G; Masi A
Neuropharmacology; 2018 Mar; 131():403-413. PubMed ID: 29339292
[TBL] [Abstract][Full Text] [Related]
15. Anti-allodynic and anti-inflammatory effects of 17α-hydroxyprogesterone caproate in oxaliplatin-induced peripheral neuropathy.
Miguel CA; Raggio MC; Villar MJ; Gonzalez SL; Coronel MF
J Peripher Nerv Syst; 2019 Mar; 24(1):100-110. PubMed ID: 30680838
[TBL] [Abstract][Full Text] [Related]
16. The orally active glutamate carboxypeptidase II inhibitor E2072 exhibits sustained nerve exposure and attenuates peripheral neuropathy.
Wozniak KM; Wu Y; Vornov JJ; Lapidus R; Rais R; Rojas C; Tsukamoto T; Slusher BS
J Pharmacol Exp Ther; 2012 Dec; 343(3):746-54. PubMed ID: 22988061
[TBL] [Abstract][Full Text] [Related]
17. Anti-allodynic effect of Buja in a rat model of oxaliplatin-induced peripheral neuropathy via spinal astrocytes and pro-inflammatory cytokines suppression.
Jung Y; Lee JH; Kim W; Yoon SH; Kim SK
BMC Complement Altern Med; 2017 Jan; 17(1):48. PubMed ID: 28088201
[TBL] [Abstract][Full Text] [Related]
18. Ibudilast suppresses oxaliplatin-induced mechanical allodynia and neurodegeneration in rats.
Egashira N; Goto Y; Takahashi R; Iba H; Yamamoto S; Watanabe T; Kubota K; Kawashiri T; Taniguchi C; Katsurabayashi S; Iwasaki K
J Pharmacol Sci; 2021 Sep; 147(1):114-117. PubMed ID: 34294361
[TBL] [Abstract][Full Text] [Related]
19. VhH anti-thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow.
van Moorsel MVA; Poolen GC; Koekman CA; Verhoef S; de Maat S; Barendrecht A; van Kleef ND; Meijers JCM; Schiffelers RM; Maas C; Urbanus RT
J Thromb Haemost; 2022 May; 20(5):1213-1222. PubMed ID: 35170225
[TBL] [Abstract][Full Text] [Related]
20. A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathy.
Kotaka M; Saito Y; Kato T; Satake H; Makiyama A; Tsuji Y; Shinozaki K; Fujiwara T; Mizushima T; Harihara Y; Nagata N; Kurihara N; Ando M; Kusakawa G; Sakai T; Uchida Y; Takamoto M; Kimoto S; Hyodo I
Cancer Chemother Pharmacol; 2020 Nov; 86(5):607-618. PubMed ID: 32965539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
